December 27, 2022Olpruva receives FDA approval for patients with some urea cycle disorders (UCD’s) December 27, 2022 - Acer Therapeutics Inc. and its collaboration partner, RELIEF THERAPEUTICS Holding SA, have announced that the U.S. Food and Drug Administration
December 23, 2022FDA approves Wegovy as anti-obesity medication for teens with once-weekly dosing. December 23, 2022 – Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Wegovy
December 23, 2022GFA Production (Xiamen) Co., Ltd. Issues Voluntary Nationwide Recall of Easy Care First Aid® Burn Cream and First Aid Kits Due to Microbial Contamination December 23, 2022 – Xiamen, Fujian, GFA Production (Xiamen) Co., Ltd. is voluntarily recalling one
December 22, 2022Accord Healthcare Inc. Issues Nationwide Voluntary Recall of Daptomycin for Injection 500 mg/vial and Daptomycin for Injection 350 mg/vial Lot Due to Product Mix-Up December 22, 2022 - Accord Healthcare, Inc. is voluntarily recalling a single lot of Daptomycin for
December 22, 2022Hospira, Inc. Issues A Voluntary Nationwide Recall For One Lot of Vancomycin Hydrochloride Injection, USP 1.5g/vial, Due To The Presence of Visible Glass Particulates December 22, 2022 - Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Vancomycin
December 22, 2022Lunsumio approval from FDA for treatment of adults with relapsed or refractory follicular lymphoma December 22, 2022 - Genentech, a member of the Roche Group, has announced that the U.S. Food and Drug Administration
December 22, 2022Sunlenca approved by FDA for use with other antiretrovirals for the treatment of HIV-1 infections December 22, 2022 - Gilead Sciences, Inc. has announced that Sunlenca ® (lenacapavir), in combination with other antiretroviral(s)
December 22, 2022NexoBrid (anacaulase-bcdb) approved for the Treatment of Severe Thermal Burns in Adults December 29, 2022 - MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation biotherapeutic